Company Presentations

2025 Application Window is Open!

This meeting will feature in-person presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering and broader regenerative medicine technologies. The presentations will be delivered live in Rome, Italy and streamed for virtual attendees. The recordings will also be uploaded into the virtual platform within 24 hours for further on-demand viewing.

Presentation Format

In-person presentations will be delivered live in Rome, Italy and streamed for virtual attendees. The recordings will also be uploaded into the virtual platform within 24 hours for further on-demand viewing.

Application Dates

All presentation requests must be received online by December 13, 2024 to be considered. Applicants will be notified if their company has been selected to present by January 13, 2025.

Selection Criteria

Company MUST be an ARM member in good standing. Non-members interested in joining the organization should contact  member@alliancerm.org for further details.
CEO or company C-level executive MUST be available to present. Should a C-level executive not be available in the end, the presentation spot will be given to another company on the waitlist.
Priority selection is given to public and late-stage, private therapeutic developers as well as enabling technology companies. Service and tools providers are still able to apply and will be given consideration if space allows.

Presentation Cost

There is NO FEE to present at this meeting. However, presenters and additional company attendees are required to register and pay to attend the conference.

Benefits of Presenting

Questions?

Brittany Miller
Manager, Events
Alliance for Regenerative Medicine
bmiller@alliancerm.org

Questions?

Brittany Miller
Manager, Events
Alliance for Regenerative Medicine
bmiller@alliancerm.org

2024 Company Presenters

  • Presentation State

By using this website you agree to accept our Privacy Policy and Terms & Conditions